Fluorescent polyimide films were manufactured using colorless, transparent polyimide (PI) as a matrix material and perylenediimide (PDI) as a covalently incorporated fluorophore. The matrix polymer was manufactured using fluorinated monomers of 4,4′-(hexafluoroisopropylidene)diphthalic anhydride (6FDA) and 2,2-bis(trifluoromethyl)benzidine. A slight excess of 6FDA was used to produce an acid anhydride-terminated polyamic acid (PAA) precursor. Amine-terminated PDI was prepared in advance through a high-temperature condensation reaction between perylene-3,4,9,10-tetracarboxylic acid dianhydride and two equivalent cycloaliphatic diamines. The acid anhydride-terminated precursor PAA was treated with the amine-terminated PDI to simultaneously extend the chain and confer fluorescence (FL), followed by chemical imidization to obtain fluorescent PIs. Well-featured PI films with a thickness of approximately 50 μm were fabricated via casting on glass slides and convection drying. The prepared PI films showed an elastic modulus of more than 4.4 GPa, a tensile strength of more than 81 MPa, a thermal decomposition temperature of more than 500 °C, at which a weight loss of 5% was observed, and a glass transition temperature of more than 306 °C. Moreover, the polymer films showed FL quantum efficiency of 5.74% or higher, with the FL color slightly differing depending on the cycloaliphatic diamine used in the synthesis of the PDI unit.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: